000 01339 a2200373 4500
005 20250517052822.0
264 0 _c20160725
008 201607s 0 0 eng d
022 _a1744-7674
024 7 _a10.1517/13543776.2015.1089233
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMusumeci, Francesca
245 0 0 _aAnalogs, formulations and derivatives of imatinib: a patent review.
_h[electronic resource]
260 _bExpert opinion on therapeutic patents
_c2015
300 _a1411-21 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aBiological Availability
650 0 4 _aChemistry, Pharmaceutical
_xmethods
650 0 4 _aDrug Design
650 0 4 _aFusion Proteins, bcr-abl
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aImatinib Mesylate
_xadministration & dosage
650 0 4 _aNanoparticles
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aPatents as Topic
700 1 _aSchenone, Silvia
700 1 _aGrossi, Giancarlo
700 1 _aBrullo, Chiara
700 1 _aSanna, Monica
773 0 _tExpert opinion on therapeutic patents
_gvol. 25
_gno. 12
_gp. 1411-21
856 4 0 _uhttps://doi.org/10.1517/13543776.2015.1089233
_zAvailable from publisher's website
999 _c25264046
_d25264046